Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
- 1 October 1997
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (12), 1932-1936
- https://doi.org/10.1016/s0959-8049(97)00226-8
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- There may be two tumor suppressor genes on chromosome arm Ip closely associated with biologically distinct subtypes of neuroblastomaGenes, Chromosomes and Cancer, 1994
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32Human Molecular Genetics, 1992
- ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSKCell, 1992
- Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological CharacteristicsJapanese Journal of Cancer Research, 1992
- Immunohistochemical analysis of N-myc protein expression in neuroblastoma: Correlation with prognosis of patientsJournal of Pediatric Surgery, 1991
- The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth FactorScience, 1991
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984